Related Experiment Video
Updated: Nov 11, 2025
09:38
A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
14.1K
Platelet function and microvesicle generation in patients with hemophilia A
Antonia Melero-Amor1, Paola Romecín2,3, David Iyú2,3
1Servicio de Hematología Hospital Universitario Virgen de la Arrixaca Murcia Spain.
Clinical Case Reports
|March 26, 2021
Summary
This study found no impact of Factor VIII (FVIII) on platelet function in severe Hemophilia A (HA) patients undergoing prophylactic treatment. These findings suggest FVIII prophylaxis does not alter platelet activity in this patient group.
Area of Science:
- Hematology
- Hemostasis
- Platelet Biology
Background:
- Severe Hemophilia A (HA) is a genetic bleeding disorder characterized by a deficiency in clotting Factor VIII (FVIII).
- Prophylactic treatment with FVIII concentrates is standard care for severe HA to prevent spontaneous bleeding episodes.
- The role of FVIII in modulating platelet function, independent of its clotting activity, remains an area of investigation.
Observation:
- This study investigated the effect of FVIII prophylaxis on platelet function in patients with severe HA.
- Platelet function was assessed in patients receiving regular FVIII infusions.
Findings:
- No significant effect of FVIII prophylaxis was observed on key platelet function parameters.
- Platelet aggregation, activation, and adhesion remained unchanged despite FVIII treatment.
Implications:
- Current FVIII prophylactic regimens in severe HA do not appear to influence platelet function.
- Further research may explore other factors affecting platelet behavior in HA patients on prophylaxis.
- These findings contribute to understanding the comprehensive hemostatic profile beyond clotting factor levels.
Related Concept Videos
01:18Structure and Function of Platelets
2.4K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
2.4K
01:22Formation of the Platelet Plug
8.0K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
8.0K
01:16Clot Retraction and Fibrinolysis
7.7K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
7.7K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.2K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.2K
01:05Introduction to Hemostasis
11.5K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
11.5K
01:24Disorders of Hemostasis
1.6K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.6K